Search

Novocure Ltd

Closed

SectorHealthcare

13.12 -7.08

Overview

Share price change

24h

Current

Min

13.81

Max

14.62

Key metrics

By Trading Economics

Income

55M

-16M

Sales

9.5M

184M

EPS

-0.13

Profit margin

-8.529

Employees

1,605

EBITDA

57M

-6.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+98.36% upside

Dividends

By Acuity

Next Earnings

29 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-169M

1.7B

Previous open

20.2

Previous close

13.12

Novocure Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

28 Oct 2026, 23:36 UTC

NovoCure Limited's shares rose in after-market trading, recovering from an earlier low to achieve a higher level later in the session.

27 Oct 2026, 20:01 UTC

NovoCure Limited is trading higher, having reached a notable peak earlier in the session.

26 Oct 2026, 20:06 UTC

Novocure Ltd shares fell sharply, marking five consecutive sessions of declines and closing lower from Friday's close, remaining below the 20-day moving average.

23 Oct 2026, 20:07 UTC

Novocure Ltd shares fell, reflecting the broader market's decline, amid economic indicators showing a slight drop in the S&P Global Composite PMI and rising oil prices.

22 Oct 2026, 20:07 UTC

Novocure Ltd shares are declining, continuing a downward trend since Wednesday, despite an early uptick; the stock hit its lowest point in the early afternoon.

20 Oct 2026, 20:08 UTC

Novocure Ltd shares advanced sharply amid a broader market rally in the health care equipment sector, pulling back slightly from a mid-session peak.

19 Oct 2026, 20:01 UTC

Novocure Ltd shares are sharply higher, reaching a peak gain of over six percent.

16 Oct 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading significantly below its 20-day moving average and near the lower end of its one-month range.

15 Oct 2026, 19:46 UTC

Novocure Ltd shares are advancing, reaching a peak cumulative return during Thursday's trading session.

14 Oct 2026, 20:13 UTC

Novocure Ltd's shares advanced modestly during after-market hours on Wednesday, reflecting a cumulative return of 0.58% since the market closed.

9 Oct 2026, 19:45 UTC

Novocure Ltd is trading higher.

8 Oct 2026, 20:06 UTC

Novocure Ltd shares fell sharply, continuing a downward trend with a notable decline since Wednesday's close, reaching their lowest point around midday.

7 Oct 2026, 20:07 UTC

Novocure Ltd shares fell sharply, continuing a decline since Tuesday's close and now trading near the bottom of their one-month range.

6 Oct 2026, 20:06 UTC

Novocure Ltd's shares declined sharply, settling near the lower end of their one-month range and below the 20-day moving average amid overall market weakness.

5 Oct 2026, 20:06 UTC

Novocure Ltd's shares advanced, recovering from an earlier dip and reaching a peak, though they remain near the lower end of their one-month trading range.

2 Oct 2026, 20:00 UTC

Novocure Ltd shares fell sharply, breaking a trend of higher daily closes and contrasting with prior upward momentum.

1 Oct 2026, 20:13 UTC

Novocure Ltd is trading higher in after-market hours, holding steady near the lower end of its one-month trading range following Thursday's close.

24 Sept 2026, 20:07 UTC

Novocure Ltd's shares fell sharply, continuing a decline since Wednesday's close, amid broader market weakness and routine fluctuations throughout the session.

21 Sept 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading below their 20-day moving average and around the midpoint of their one-month trading range.

18 Sept 2026, 23:36 UTC

Novocure Ltd is trading modestly higher in after-market hours, recovering from a decline earlier in the day but remaining below its 20-day moving average.

17 Sept 2026, 19:51 UTC

Novocure Ltd is trading higher amid a broader market rally, boosted by strong labor market data and a positive Philadelphia Fed Manufacturing Index.

16 Sept 2026, 23:06 UTC

Novocure Ltd has gained modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

15 Sept 2026, 19:26 UTC

Novocure Ltd. shares are advancing, rebounding from an earlier low, after three consecutive sessions of gains. The stock remains below its 20-day moving average.

14 Sept 2026, 20:21 UTC

Novocure Ltd shares are higher in after-market hours, continuing a trend of daily gains. No specific news was identified to explain the movement.

11 Sept 2026, 19:36 UTC

Novocure shares are trading higher, buoyed by positive sentiment in the health care equipment sector and broader market dynamics despite some volatility earlier in the session.

10 Sept 2026, 19:46 UTC

Novocure Ltd. shares are lower, continuing a three-session decline amid broader market pressure from the European Central Bank's interest rate hike and inflation warnings.

9 Sept 2026, 23:06 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a three-session decline and remaining below their 20-day moving average. No specific news was identified.

8 Sept 2026, 22:26 UTC

Shares of Novocure Ltd. are higher in after-market trading, fluctuating within a narrow range since Tuesday's close and remaining near the lower end of their one-month range.

2 Sept 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

1 Sept 2026, 19:11 UTC

News

Novocure Ltd shares are lower following a data breach affecting over 1,400 U.S. records, disclosed in a regulatory filing earlier today.

Peer Comparison

Price change

Novocure Ltd Forecast

Price Target

By TipRanks

98.36% upside

12 Months Forecast

Average 29 USD  98.36%

High 29 USD

Low 29 USD

Based on 1 Wall Street analysts offering 12 month price targets forNovocure Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat